CEPHEID

Cepheid specializes in the design, manufacturing, and support of molecular diagnostic systems and associated reagents, with deep expertise in automated nucleic acid amplification technology and point-of-care testing platforms. The company develops and supplies integrated diagnostic instruments, test kits, and consumables that enable rapid, lab-quality pathogen detection in field and clinical environments, particularly for infectious disease screening and public health surveillance. Their technical capabilities span molecular biology, microfluidics, real-time PCR instrumentation, and closed-system assay design, with a focus on ruggedized, user-friendly platforms suitable for low-resource or high-throughput settings. Cepheid’s solutions are engineered for minimal operator intervention, high reproducibility, and seamless integration with existing laboratory workflows, distinguishing them in mission-critical diagnostic applications. The contractor maintains a strong and consistent presence with the Department of Defense and the Department of Veterans Affairs, delivering diagnostic systems and supplies to military medical facilities and VA laboratories for infectious disease monitoring, biodefense readiness, and troop health protection. Additional engagement with the Department of Health and Human Services, including the CDC, supports public health emergency response and laboratory network modernization. Work with these agencies centers on sustaining and expanding deployed GeneXpert systems and ensuring continuous availability of validated test kits. Cepheid’s primary industry focus lies in in-vitro diagnostic substance manufacturing and analytical laboratory instrument manufacturing, positioning them as a leader in automated molecular diagnostics for government health and defense missions. Their market role combines hardware engineering with proprietary assay development, serving verticals that demand rapid, accurate, and deployable testing capabilities. As a California-based entity structured as a 2L, Cepheid operates without federal small business certifications but maintains a robust government-facing supply chain and service infrastructure aligned with federal medical and defense standards.